T0	Disease 200 206	cancer
#1	AnnotatorNotes T0	DOID:162
T1	Disease 388 394	cancer
T19	Disease 918 931	breast cancer
#4	AnnotatorNotes T19	DOID:1612
T21	Disease 1076 1104	advanced lung adenocarcinoma
#5	AnnotatorNotes T21	DOID:3910
T22	Drug 1118 1127	gefitinib
T25	Disease 1233 1259	non‐small cell lung cancer
#7	AnnotatorNotes T25	DOID:3908
T27	Disease 1261 1266	NSCLC
#9	AnnotatorNotes T27	DOID:3908
T28	Disease 1339 1360	radiation pneumonitis
#10	AnnotatorNotes T28	D017564
T31	Disease 1550 1555	tumor
T32	Disease 1609 1633	grade 3–4 oral mucositis
#12	AnnotatorNotes T32	not found
T8	Disease 551 562	lung cancer
#15	AnnotatorNotes T8	DOID:1324
T2	Gene-Protein 483 488	ATG10
#2	AnnotatorNotes T2	HGNC:20315
T5	Biomarker 483 524	ATG10 rs10514231, rs1864182 and rs1864183
R1	Prognostic-Poor Arg1:T5 Arg2:T8	
T3	Gene-Protein 603 608	ATG10
T4	Gene-Protein 653 658	ATG10
T6	Gene-Protein 832 837	ATG10
T7	Drug-Class 1285 1297	radiotherapy
T9	Drug-Class 1514 1526	radiotherapy
T13	Gene-Protein 1163 1170	ATG16L2
#6	AnnotatorNotes T13	HGNC:25464
T15	Gene-Protein 1442 1449	ATG16L2
T18	Drug-Class 749 761	radiotherapy
T20	Biomarker 832 862	ATG10 rs1864182 and rs10514231
R2	Risk-Reduce Arg1:T20 Arg2:T19	
T16	GeneFamily 1015 1019	ATGs
T17	Biomarker 993 1019	genetic variations in ATGs
R3	Association Arg1:T17 Arg2:T21	
#14	AnnotatorNotes T22	CHEMBL939
T23	Biomarker 1163 1181	ATG16L2 rs10898880
R4	Prognostic-Good Arg1:T23 Arg2:T25	
T24	Biomarker 1442 1460	ATG16L2 rs10898880
T26	GeneFamily 309 313	ATGs
#8	AnnotatorNotes T26	family:1022
T29	Biomarker 309 313	ATGs
#16	AnnotatorNotes T29	C000616891
R5	Association Arg1:T29 Arg2:T1	
T14	Disease 778 783	tumor
#3	AnnotatorNotes T14	DOID:162
R6	Mediated-Non-Response Arg1:T18 Arg2:T14	
T30	Biomarker 653 695	ATG10 rs10514231, rs1864183, and rs4703533
R7	Mediator Arg1:T18 Arg2:T30	
T10	Biomarker 603 619	ATG10 expression
R8	Risk-Factor Arg1:T23 Arg2:T28	
R9	Mediator Arg1:T9 Arg2:T24	
R11	Mediated-Response Arg1:T9 Arg2:T31	
R10	Risk-Factor Arg1:T24 Arg2:T32	
